Pharming Group Nv Stock Volatility
| PHGUF Stock | USD 0.95 0.12 11.21% |
Pharming Group NV maintains Sharpe Ratio (i.e., Efficiency) of -0.11, which implies the firm had a -0.11% return per unit of risk over the last 3 months. Pharming Group NV exposes twenty different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Pharming Group's Variance of 7.04, risk adjusted performance of (0.06), and Coefficient Of Variation of (909.01) to confirm the risk estimate we provide. Key indicators related to Pharming Group's volatility include:
420 Days Market Risk | Chance Of Distress | 420 Days Economic Sensitivity |
Pharming Group Pink Sheet volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Pharming daily returns, and it is calculated using variance and standard deviation. We also use Pharming's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Pharming Group volatility.
Pharming |
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as Pharming Group can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game. Here, they may decide to buy additional stocks of Pharming Group at lower prices. For example, an investor can purchase Pharming stock that has halved in price over a short period. This will lower your average cost per share, thereby improving your portfolio's performance when the markets normalize. Similarly, when the prices of Pharming Group's stock rises, investors can sell out and invest the proceeds in other equities with better opportunities. Investing when markets are volatile with better valuations will accord both investors and companies the opportunity to generate better long-term returns.
Moving together with Pharming Pink Sheet
Moving against Pharming Pink Sheet
Pharming Group Market Sensitivity And Downside Risk
Pharming Group's beta coefficient measures the volatility of Pharming pink sheet compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Pharming pink sheet's returns against your selected market. In other words, Pharming Group's beta of 0.62 provides an investor with an approximation of how much risk Pharming Group pink sheet can potentially add to one of your existing portfolios. Pharming Group NV exhibits very low volatility with skewness of -1.86 and kurtosis of 11.33. Pharming Group NV is a potential penny stock. Although Pharming Group may be in fact a good instrument to invest, many penny pink sheets are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Pharming Group NV. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Pharming instrument if you perfectly time your entry and exit. However, remember that penny pink sheets that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.
3 Months Beta |Analyze Pharming Group NV Demand TrendCheck current 90 days Pharming Group correlation with market (NYSE Composite)Pharming Beta |
Pharming standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.
Standard Deviation | 2.74 |
It is essential to understand the difference between upside risk (as represented by Pharming Group's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of Pharming Group's daily returns or price. Since the actual investment returns on holding a position in pharming pink sheet tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in Pharming Group.
Pharming Group NV Pink Sheet Volatility Analysis
Volatility refers to the frequency at which Pharming Group pink sheet price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Pharming Group's price changes. Investors will then calculate the volatility of Pharming Group's pink sheet to predict their future moves. A pink sheet that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A pink sheet with relatively stable price changes has low volatility. A highly volatile pink sheet is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Pharming Group's volatility:
Historical Volatility
This type of pink sheet volatility measures Pharming Group's fluctuations based on previous trends. It's commonly used to predict Pharming Group's future behavior based on its past. However, it cannot conclusively determine the future direction of the pink sheet.Implied Volatility
This type of volatility provides a positive outlook on future price fluctuations for Pharming Group's current market price. This means that the pink sheet will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on Pharming Group's to be redeemed at a future date.Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. Pharming Group NV Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.
Pharming Group Projected Return Density Against Market
Assuming the 90 days horizon Pharming Group has a beta of 0.6221 indicating as returns on the market go up, Pharming Group average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Pharming Group NV will be expected to be much smaller as well.Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Pharming Group or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Pharming Group's price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Pharming pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Pharming Group NV has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite. Predicted Return Density |
| Returns |
What Drives a Pharming Group Price Volatility?
Several factors can influence a pink sheet's market volatility:Industry
Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.Political and Economic environment
When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.The Company's Performance
Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.Pharming Group Pink Sheet Risk Measures
Assuming the 90 days horizon the coefficient of variation of Pharming Group is -881.12. The daily returns are distributed with a variance of 7.5 and standard deviation of 2.74. The mean deviation of Pharming Group NV is currently at 1.13. For similar time horizon, the selected benchmark (NYSE Composite) has volatility of 0.62
α | Alpha over NYSE Composite | -0.35 | |
β | Beta against NYSE Composite | 0.62 | |
σ | Overall volatility | 2.74 | |
Ir | Information ratio | -0.14 |
Pharming Group Pink Sheet Return Volatility
Pharming Group historical daily return volatility represents how much of Pharming Group pink sheet's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The company shows 2.738% volatility of returns over 90 . By contrast, NYSE Composite accepts 0.6371% volatility on return distribution over the 90 days horizon. Performance |
| Timeline |
About Pharming Group Volatility
Volatility is a rate at which the price of Pharming Group or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Pharming Group may increase or decrease. In other words, similar to Pharming's beta indicator, it measures the risk of Pharming Group and helps estimate the fluctuations that may happen in a short period of time. So if prices of Pharming Group fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.Pharming Group N.V., a biopharmaceutical company, develops and commercialize protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical needs in the United States, Europe, and internationally. Pharming Group N.V. is headquartered in Leiden, the Netherlands. Pharming Grp operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 277 people.
Pharming Group's stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on Pharming Pink Sheet over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much Pharming Group's price varies over time.
3 ways to utilize Pharming Group's volatility to invest better
Higher Pharming Group's stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of Pharming Group NV stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. Pharming Group NV stock volatility can provide helpful information for making investment decisions in the following ways:- Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of Pharming Group NV investment. A higher volatility means higher risk and potentially larger changes in value.
- Identifying Opportunities: High volatility in Pharming Group's stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
- Diversification: Understanding how the volatility of Pharming Group's stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
Pharming Group Investment Opportunity
Pharming Group NV has a volatility of 2.74 and is 4.28 times more volatile than NYSE Composite. Compared to the overall equity markets, volatility of historical daily returns of Pharming Group NV is lower than 24 percent of all global equities and portfolios over the last 90 days. You can use Pharming Group NV to protect your portfolios against small market fluctuations. The pink sheet experiences a very speculative downward sentiment. The market maybe over-reacting. Check odds of Pharming Group to be traded at $0.9025 in 90 days.Average diversification
The correlation between Pharming Group NV and NYA is 0.14 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Pharming Group NV and NYA in the same portfolio, assuming nothing else is changed.
Pharming Group Additional Risk Indicators
The analysis of Pharming Group's secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Pharming Group's investment and either accepting that risk or mitigating it. Along with some common measures of Pharming Group pink sheet's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Risk Adjusted Performance | (0.06) | |||
| Market Risk Adjusted Performance | (0.48) | |||
| Mean Deviation | 1.06 | |||
| Coefficient Of Variation | (909.01) | |||
| Standard Deviation | 2.65 | |||
| Variance | 7.04 | |||
| Information Ratio | (0.14) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential pink sheets, we recommend comparing similar pink sheets with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Pharming Group Suggested Diversification Pairs
Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Pharming Group as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Pharming Group's systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Pharming Group's unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Pharming Group NV.
When determining whether Pharming Group NV is a strong investment it is important to analyze Pharming Group's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Pharming Group's future performance. For an informed investment choice regarding Pharming Pink Sheet, refer to the following important reports: Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pharming Group NV. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Pharming Pink Sheet analysis
When running Pharming Group's price analysis, check to measure Pharming Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharming Group is operating at the current time. Most of Pharming Group's value examination focuses on studying past and present price action to predict the probability of Pharming Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharming Group's price. Additionally, you may evaluate how the addition of Pharming Group to your portfolios can decrease your overall portfolio volatility.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |